Evidence map›Paper›PMID 40056137›Full record

ArticleMedical physics2025

Compressed radiotherapy treatment planning: A new paradigm for rapid and high-quality treatment planning optimization.

Mojtaba Tefagh, Gourav Jhanwar, Masoud Zarepisheh

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mojtaba TefaghEdinburgh Futures Institute, University of Edinburgh, Edinburgh, Scotland.
Gourav JhanwarDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Masoud ZarepishehDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
MSK Cancer CenterNCI NIH HHS P30 CA008748NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundRadiotherapy treatment planning involves solving large-scale optimization problems that are often approximated and solved sub-optimally due to time constraints. Central to these problems is the dose influence matrix-also known as the dij matrix or dose deposition matrix-which quantifies the radiation dose delivered from each beamlet to each voxel. Our findings demonstrate that this matrix is highly compressible, enabling a compact representation of the optimization problems and allowing them to be solved more efficiently and accurately. PURPOSE: To develop a compressed radiotherapy treatment planning framework based on a sparse-plus-low-rank matrix compression technique. This approach circumvents conventional sparsification methods that discard small matrix elements-often representing scattering components-and may compromise the quality of the treatment plan.

methodsWe precompute the primary (

resultsCompressed planning offers superior trade-offs between accuracy and computational efficiency, adjustable through algorithm parameters. For example, we achieved average reductions in dose discrepancy and optimization time of 73% and 20%, respectively, for 10 prostate patients, and 83% and 13% for lung patients. By using the compressed matrix within our automated ECHO planning system, we maintained comparable PTV coverage while significantly enhancing the sparing of organs at risk. Specifically, mean doses to the bladder and rectum for prostate patients were reduced by 8.8% and 12.5%, respectively. For lung patients, mean doses to the lungs (left and right, excluding GTV) and heart were reduced by 10.8% and 11.2%, respectively, compared to plans generated with the sparsified matrix.

conclusionThe proposed framework enables rapid, high-quality treatment planning without compromising data integrity and plan quality. By integrating that with recent advancements in AI-driven influence matrix calculations, this platform has the potential to facilitate fast and efficient online adaptive radiotherapy treatment planning, enhancing both speed and accuracy in clinical workflows.

Indexed as

Radiotherapy Planning, Computer-AssistedHumansQuality ControlRadiotherapy DosageTime Factorscompressionconstrained optimizationIMRT treatment planningtreatment planning optimization

Identifiers

PMID40056137
PMCPMC12151756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.